Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 18 stocks, with a combined market cap of $3,012.34 billion, total revenue of $603.35 billion and a weighted average PE ratio of 34.97.

Market Cap
3,012.34B
Revenue
603.35B
Profits
86.13B
PE Ratio
34.97
Profit Margin
14.28%
Dividend Yield
1.96%

18 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company861.74B-0.84%4,526,56635.93B
2JNJJohnson & Johnson351.45B-0.28%3,715,01681.80B
3MRKMerck & Co., Inc.323.49B-0.14%5,644,60861.40B
4ABBVAbbVie Inc.293.06B-2.59%4,108,03954.40B
5AZNAstraZeneca PLC238.71B-1.22%3,003,59047.61B
6NVSNovartis AG208.25B-0.09%1,073,09049.92B
7AMGNAmgen Inc.166.71B-0.08%1,542,11329.53B
8PFEPfizer Inc.157.70B-1.38%16,889,77555.09B
9SNYSanofi121.63B-2.12%2,639,97051.60B
10GILDGilead Sciences, Inc.85.22B-0.35%4,835,48727.45B
11BMYBristol-Myers Squibb Company82.00B-2.06%14,091,47045.53B
12GSKGSK plc77.91B-0.44%3,147,78239.41B
13BIIBBiogen Inc.33.32B-1.27%860,1439.66B
14GRFSGrifols, S.A.5.33B3.82%838,7867.32B
15OGNOrganon & Co.5.17B-0.94%858,4016.35B
16SCLXScilex Holding Company349.70M2.66%1,547,61647.05M
17AMRNAmarin Corporation plc289.57M2.77%945,831277.46M
18MIRAMIRA Pharmaceuticals, Inc.8.91M-8.54%51,851-